Deepti Radia - Concepedia

Author

Deepti Radia

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

D Radia, D. RADIA, D. Radia, Deepti H Radia, Deepti H. Radia, Deepti Radia, Radia, D., V. Prendki

231

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust Heidelberg University University Hospital Heidelberg Stanford University King's College London

About

Deepti Radia is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	845
2	Health Sciences	7	7	322
3	Allergy	2	2	32
4	Engineering	1	1	30
5	Blood Transplantation	1	1	15

Deepti Radia

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Journal of Clinical Oncology	2012	441
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients Robyn M. Scherber, Amylou C. Dueck, Peter Johansson, Blood	2011	332
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H Claire Dearden, Estella Matutes, Bruno Cazin, Blood	2001	315
The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis Ruben A. Mesa, Susan M. Schwager, Deepti Radia, Leukemia Research Quality Of LifeLife AssessmentPsychiatrySymptomatic ResponsePrognosis	2009	226
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis Peter Valent, Luís Escribano, Sigurd Broesby‐Olsen, Allergy European Competence NetworkMast Cell DisorderSuspected MastocytosisDiagnosisPathology	2014	170
Guideline for the investigation and management of eosinophilia Nauman M. Butt, Jonathan Lambert, Sahra Ali, British Journal of Haematology	2017	162
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial Daniel J. DeAngelo, Deepti Radia, Tracy I. George, Nature Medicine	2021	139
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial Jason Gotlib, Andreas Reiter, Deepti Radia, Nature Medicine	2021	135
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients Holly L. Geyer, Robyn M. Scherber, Amylou C. Dueck, Blood	2014	89
Experience with pegylated interferon -2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients Krisstina Gowin, Prakash Thapaliya, John Samuelson, Haematologica ImmunologyPathologyAdvanced Myeloproliferative NeoplasmsPharmacotherapyImmunotherapy	2012	85

Page 1